RAPT Therapeutics, Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
0.00 |
0.77 |
10.19 |
0.81 |
83.70 |
18.15 |
Przychód Δ r/r |
0.00% |
inf% |
1226.15% |
-92.10% |
10292.93% |
-78.32% |
Przychód (min) |
0.00 |
0.77 |
10.19 |
0.81 |
83.70 |
18.15 |
Przychód (max) |
0.00 |
0.77 |
10.19 |
0.81 |
83.70 |
18.15 |
EBITDA (średnia) |
0.00 |
-0.15 |
-2.04 |
-0.16 |
-16.74 |
-3.63 |
EBIT (średnia) |
0.00 |
-0.15 |
-2.04 |
-0.16 |
-16.74 |
-3.63 |
EBIT % |
0.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
Zysk netto (średni) |
-605.60 |
-102.86 |
-103.41 |
-97.66 |
-41.98 |
-44.43 |
Zysk netto % |
-inf% |
-13387.38% |
-1014.88% |
-12126.43% |
-50.16% |
-244.79% |
EPS (średnia) |
-14.71 |
-2.52 |
-3.23 |
-2.63 |
-1.03 |
-1.09 |
Liczba analityków (Przychody) |
0 |
4 |
4 |
2 |
1 |
1 |
Liczba analityków (EPS) |
4 |
4 |
6 |
3 |
1 |
1 |
symbol |
RAPT |
RAPT |
RAPT |
RAPT |
RAPT |
RAPT |